
HLB Therapeutics Co.,Ltd. — Investor Relations & Filings
HLB Therapeutics Co., Ltd. is a biopharmaceutical company specializing in the development of innovative, first-in-class drugs for rare and intractable diseases. The company's clinical-stage pipeline focuses on addressing unmet medical needs in ophthalmology and oncology. Key development programs include RGN-259, a therapeutic agent for Dry Eye Disease and Neurotrophic Keratopathy, and OKN-007 for the treatment of Glioblastoma Multiforme. Additionally, the company is advancing a Natural Killer (NK) cell therapy through late-stage clinical trials to provide new therapeutic options for patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 주식등의대량보유상황보고서(일반) | 2026-06-02 | Korean | |
| 분기보고서 (2026.03) | 2026-05-15 | Korean | |
| 주식등의대량보유상황보고서(일반) | 2026-04-21 | Korean | |
| 전환사채(해외전환사채포함)발행후만기전사채취득 | 2026-04-01 | Korean | |
| 정기주주총회결과 | 2026-03-27 | Korean | |
| 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-03-27 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47927812 | 주식등의대량보유상황보고서(일반) | 2026-06-02 | Korean | ||
| 46354519 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 34698114 | 주식등의대량보유상황보고서(일반) | 2026-04-21 | Korean | ||
| 33134768 | 전환사채(해외전환사채포함)발행후만기전사채취득 | 2026-04-01 | Korean | ||
| 33058879 | 정기주주총회결과 | 2026-03-27 | Korean | ||
| 33058873 | 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-03-27 | Korean | ||
| 33058854 | 본점소재지변경 | 2026-03-27 | Korean | ||
| 33038158 | 기업설명회(IR)개최 | 2026-03-25 | Korean | ||
| 33038143 | 기업설명회(IR)개최 | 2026-03-25 | Korean | ||
| 32985405 | 감사보고서제출 | 2026-03-19 | Korean | ||
| 32985399 | 사업보고서 (2025.12) | 2026-03-19 | Korean | ||
| 32983212 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-19 | Korean | ||
| 32969462 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-18 | Korean | ||
| 32960361 | 주식등의대량보유상황보고서(일반) | 2026-03-17 | Korean | ||
| 32928701 | 권리락 (무상증자) | 2026-03-11 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Apontis Pharma AG
Develops and markets fixed-dose combination drugs (Single P…
|
APPH | DE | Manufacturing |
|
Appili Therapeutics Inc.
Biopharmaceutical company developing novel medicines for in…
|
APLI | CA | Manufacturing |
|
Applied BioCode
Develops and manufactures high-throughput multiplex molecul…
|
6598 | TW | Manufacturing |
|
Applied Therapeutics, Inc.
Clinical-stage biopharma developing novel drugs for rare me…
|
APLT | US | Manufacturing |
|
Aprogen Biologics Inc.
Develops and manufactures novel biologics and biosimilar an…
|
003060 | KR | Manufacturing |
|
Aprogen, Inc
Develops and manufactures biologic medicines, including bio…
|
007460 | KR | Manufacturing |
|
Aptabio Therapeutics Inc.
Develops drugs for intractable diseases by regulating oxida…
|
293780 | KR | Manufacturing |
|
Aptamer Sciences Inc
Clinical-stage company developing aptamer-based therapeutic…
|
291650 | KR | Manufacturing |
|
Aptorum Group Ltd
Clinical-stage biopharma developing therapeutics for oncolo…
|
APM | US | Manufacturing |
|
Aptus Pharma Limited
Develops and manufactures cardiovascular, metabolic, and ga…
|
544529 | IN | Manufacturing |
HLB Therapeutics Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/15813/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=15813 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=15813 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=15813 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 15813}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for HLB Therapeutics Co.,Ltd. (id: 15813)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.